Gain Therapeutics: The Case For GCase In Parkinson's And Buyout Potential
Seeking Alpha,
Follow Summary Gain Therapeutics' drug candidate GT-02287 targets GCase and lysosomal dysfunction, potentially succeeding where…
Follow Summary Gain Therapeutics' drug candidate GT-02287 targets GCase and lysosomal dysfunction, potentially succeeding where…
New research shows that an innovative strategy for treating Parkinson's disease has proven successful in neurons that derive…